SecBot SecBot

BSX

BOSTON SCIENTIFIC CORP
NYSE· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0000885725 Healthcare & Medical Devices
$43.78 −0.56 (−1.27%)
Nov 16 4:00 PM ET · prev $44.34
Market cap
$64.1B
Large cap
Consensus
Buy
65% Buy or better · 37 analysts
Median target
$49.00
+12% · range $41.00–60.00
1 year
−57.0%
from $101.76 · Nov 17
30 days
−1.4%
from $44.39
52-week range
$41.58–101.76
−57% from high · low Oct 7
Avg volume 20D
19.86M
Oct 28 spike 69.84M
Short interest
35.11M
≈2.4% of shares · −13.7%
Days to cover
1.6
at average volume
Insider net
+$10.0M
5 buyers · 0 sellers · since Feb 12
New fund stakes
2
Q2 2026 13F · 5 exits
Reddit crowd
50°
Neutral · 1 mention this week
SecBot read BEARISH 8 reports · 90 days
Balance 5 bearish · 0 bullish · 2 mixed · 1 neutral oldest → newest, height = score
Avg score ·High conf. 6/8

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

  • May 19 to May 20 ▲ 2 days of insider buys: $554.0K by 3 insiders, avg $56.53
  • May 27 to Jun 5 ▼ 3 sells: Ro Khanna, John Boozman and 1 more sold $1,001 - $15,000, last disclosed Jul 13
  • May 29 to Jun 5 ▲ 3 buys: Gilbert Cisneros, Ro Khanna bought $1,001 - $15,000, last disclosed Jul 8
  • Jul 8 to Jul 10 3 court rulings: Hansen v. Boston Scientific Corp. et al; Greenberg v. Boston Scientific Corporation et al and 1 more
  • Jul 31 to Aug 5 ▲ 4 days of insider buys: $9.4M by 3 insiders, avg $48.25
  • Aug 10 to Aug 18 ▲ 2 buys: Ro Khanna, Gilbert Cisneros bought $1,001 - $15,000, last disclosed Sep 11
  • Aug 25 ▲ 1 insider buy $100.4K at $49.22
  • Aug 31 to Sep 11 ▼ 5 sells: Kevin Hern, Ro Khanna sold, last disclosed Oct 9
  • Aug 31 ▼ Short interest jumps 74.4% to 48.17M
  • Oct 28 ▼ Boston Scientific reported Q3 2026 net sales of $5.138 billion, up 1…
  • Oct 28 ▲ Earnings: BSX Q3 2026 Earnings: EPS $0.73 (+1.1% vs est)
  • Oct 30 ▼ TD Cowen downgrades

Signal stack

Where each data set points today.

  • InsidersBULLISH

    5 insiders bought $10.0M at an average $48.65. No open-market sales. Price is 10% below their cost.

  • InstitutionsMIXED

    Q2 2026: 80 added (2 new), 97 trimmed or exited.

  • AnalystsBULLISH

    24 of 37 rate it Buy or better. Median target $49.00 (+12%).

  • Short sellersSTEADY

    Short interest −13.7% to 35.11M shares. 1.6 days to cover, ≈2.4% of shares.

  • TrendRANGE

    0% below its 50-day average.

  • SocialQUIET

    Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup is alerting.

Who's buying

13F· Q2 2026
2
new positions
5
exits
FundMoveSharesValue
PRIMECAP MANAGEMENT CO/CA/ADD50,520,914$2.2B
FMR LLCTRIM45,702,845$2.0B
MASSACHUSETTS FINANCIAL SERVICES CO /MA/DOUBLED24,859,191$1.5B
JPMORGAN CHASE & COTRIM23,907,838$1.0B
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPADD23,293,913$994.2M
Capital Research Global InvestorsDOUBLED14,180,571$605.3M
BANK OF AMERICA CORP /DE/TRIM13,027,783$556.0M
FIL LtdDOUBLED12,332,054$526.3M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

37 analysts
Buy 65% rate it Buy or better
Strong Buy8Buy16Hold12Sell1Strong Sell0
12-month targets · 28 analysts

Price is inside the target range. Median implies +12%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Oct 30, 2026TD Cowen
DOWNGRADE
DOWNGRADEHold
Oct 30, 2026Barclays
MAINTAIN
MAINTAINEqual-Weight
Oct 29, 2026Jefferies
DOWNGRADE
DOWNGRADEHold
Oct 29, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
Oct 29, 2026Bernstein
MAINTAIN
MAINTAINOutperform
Oct 29, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 12, 2026 Other
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX
NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
Nov 4, 2026 Insider
Mahoney Michael F gifted 102,249 shares
Chairman, President & CEO
Nov 4, 2026 Insider
Mahoney Michael F gifted 149,992 shares
Chairman, President & CEO
Nov 1, 2026 Insider
O'Sullivan Miriam surrendered for taxes 1,872 shares
SVP, Chief HR Officer @ $41.98 ($78.6K)
Oct 28, 2026 SEC
Boston Scientific reported Q3 2026 net sales of $5.138 billion, up 1.5% YoY, missing the $5.05B consensus. Adjusted…
8-K · Impact 6/10
Oct 28, 2026 SEC
Boston Scientific reported Q3 2026 adjusted EPS of $0.73, in line with the $0.72 consensus, on revenue of $5.138B…
PRESS-RELEASE · Impact 5/10
Oct 23, 2026 SEC
A mixed institutional cluster in BSX for Q3 2026 shows 6 buyers adding $140.1M in new positions (led by Assenagon's…
INST-CLUSTER · Impact 4/10
Oct 13, 2026 Congress
Ro Khanna buy
$1,001 - $15,000 · House

Insider ledger

Form 4
$10.0M
bought · 5 insiders
$0
sold · 0 insiders
−10.0%
vs their $48.65 cost
DateInsiderTypeValue
Nov 4, 2026
Mahoney Michael F
Chairman, President & CEO
Nov 4, 2026
GIFT102,249 sh
Nov 4, 2026
Mahoney Michael F
Chairman, President & CEO
Nov 4, 2026
GIFT149,992 sh
Nov 1, 2026
O'Sullivan Miriam
SVP, Chief HR Officer
Nov 1, 2026
TAX W/H$78.6K
Nov 1, 2026
O'Sullivan Miriam
SVP, Chief HR Officer
Nov 1, 2026
EXERCISE3,871 sh
Sep 2, 2026
O'Connor Padraig Andrew
EVP, Global Operations
Sep 2, 2026
EXERCISE1,171 sh
Sep 2, 2026
O'Connor Padraig Andrew
EVP, Global Operations
Sep 2, 2026
TAX W/H$27.4K
Aug 25, 2026
Morano Susan E
Director
Aug 25, 2026
BUY$100.4K
Aug 11, 2026
Woodworth Emily
SVP, Global Controller and CAO
Aug 11, 2026
PLAN TRADE$150.0K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Congressional trades
BSX trades disclosed by members of Congress, with disclosure delay.
6 members · 15 buys / 15 sells
DateMemberType AmountDisclosed
Oct 13, 2026 Ro KhannaDHouse Child account · Boston Scientific Corp BUY $1K–$15K Nov 5, 2026 +23d
Oct 7, 2026 Ro KhannaDHouse Spouse account · Boston Scientific Corp SELL $1K–$15K Nov 5, 2026 +29d
Sep 11, 2026 Ro KhannaDHouse Child account · Boston Scientific Corp SELL $1K–$15K Oct 7, 2026 +26d
Sep 9, 2026 Kevin HernRHouse Joint account · Boston Scientific Corp SELL $50K–$100K Sep 25, 2026 +16d
Sep 4, 2026 Ro KhannaDHouse Spouse account · Boston Scientific Corp SELL $1K–$15K Oct 7, 2026 +33d
Sep 4, 2026 Kevin HernRHouse Joint account · Boston Scientific Corp SELL $50K–$100K Sep 25, 2026 +21d
Sep 3, 2026 Kevin HernRHouse Child account · Boston Scientific Corp SELL $1K–$15K Sep 25, 2026 +22d
Sep 3, 2026 Kevin HernRHouse Boston Scientific Corp SELL $1K–$15K Sep 25, 2026 +22d
Sep 3, 2026 Kevin HernRHouse Child account · Boston Scientific Corp SELL $1K–$15K Sep 25, 2026 +22d
Aug 31, 2026 Kevin HernRHouse Joint account · Boston Scientific Corp SELL $15K–$50K Sep 25, 2026 +25d

Short side

FINRA· Oct 30, 2026
35,113,858
shares short
-13.7%
vs prior settlement
1.6
days to cover
≈2.4%
of shares outstanding
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 12, 2026
Press release
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX
NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston…
Nov 2, 2026
Press release
SIMPLAAFY study of the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device meets primary endpoints
Both post-implant monotherapies in the trial achieved non-inferiority compared to dual anti-platelet therapy (DAPT) supporting the potential to…
Oct 28, 2026
Earnings
Boston Scientific announces results for third quarter 2026
MARLBOROUGH, Mass., Oct. 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.138 billion during the third…
Oct 28, 2026
Earnings result
BSX Q3 2026 Earnings: EPS $0.73 (+1.1% vs est)
Aug 31, 2026
Short interest
Short Interest: BSX up 74% to 48.2M shares
Settlement 2026-08-31 | Days to cover: 2.29 | ≈3.32% of shares outstanding (est.)
Reddit Mentions per day, 14 days
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 1 1 in posts · 0 in comments
Recent posts
All social signals and their track records

Washington

Corporate Lobbying

33 lobbying filings and 12 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

SecBot reports

22 filings · 3 bullish · 7 bearish · 4 mixed · 8 neutral
All BSX filing & press-release reports (22)